vintor 6000iu injection - Recombinant Human Erythropoietin Alfa (6000IU) medicine

Epofit 6000 IU Injection: Comprehensive Medicine Guide

No reviews yet
🏭 Emcure Pharmaceuticals Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Sep 22, 2026
⚠️ Nephrotoxicity Risk 📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: High
Reviewed by
SaathiMed Expert Panel | Sep 22, 2026

When to Call Your Doctor IMMEDIATELY

  • Chest pain, shortness of breath, or difficulty breathing
  • Sudden weakness or numbness on one side of the body
  • Severe headache with confusion or visual changes
  • Swelling, pain, or redness in one leg
  • Sudden loss of response to therapy or severe fatigue
  • Seizures
  • Signs of allergic reaction: rash, itching, swelling of face/lips/throat

If experiencing severe symptoms, call emergency services immediately.

What is vintor 6000iu injection used for?

This medicine is a recombinant human erythropoietin alfa injection used to treat anemia in chronic kidney disease, chemotherapy-induced anemia, and anemia in HIV patients on zidovudine. It stimulates red blood cell production and must be administered by a healthcare professional.

  • Generic Name: Recombinant Human Erythropoietin Alfa (6000IU)
  • Manufacturer: Emcure Pharmaceuticals Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 vintor 6000iu injection के बारे में (Hindi Summary)

उपयोग: यह दवा रक्ताल्पता (एनीमिया) के इलाज के लिए उपयोग की जाती है, विशेष रूप से क्रोनिक किडनी रोग, कीमोथेरेपी से होने वाली एनीमिया, और एचआईवी रोगियों में जिडोवुडीन के कारण होने वाली एनीमिया में। यह लाल रक्त कोशिकाओं के उत्पादन को उत्तेजित करती है। यह इंजेक्शन के रूप में दी जाती है और इसे डॉक्टर या नर्स द्वारा ही लगाया जाना चाहिए।

साइड इफेक्ट्स: सामान्य दुष्प्रभावों में उच्च रक्तचाप, सिरदर्द, थकान, दस्त, मतली, उल्टी और इंजेक्शन स्थल पर प्रतिक्रिया शामिल हैं। गंभीर दुष्प्रभावों में दिल का दौरा, स्ट्रोक, रक्त के थक्के, दौरे और शुद्ध लाल कोशिका अप्लासिया शामिल हो सकते हैं। यदि आपको सीने में दर्द, सांस लेने में कठिनाई, या पैरों में सूजन हो, तो तुरंत डॉक्टर से संपर्क करें।

सुरक्षा सलाह: यह दवा केवल डॉक्टर की देखरेख में ही दी जानी चाहिए। स्वयं इंजेक्शन न लगाएं। नियमित रूप से हीमोग्लोबिन, रक्तचाप और आयरन की जांच कराएं। गर्भावस्था या स्तनपान के दौरान डॉक्टर से सलाह लें। इस दवा को 2-8°C पर रेफ्रिजरेटर में रखें, जमने न दें।

💡 Did You Know? Over 80% of the antiretroviral drugs used globally to combat AIDS are supplied by Indian pharmaceutical companies.

💊 vintor 6000iu injection Uses & Benefits

[{"condition":"Anemia of chronic kidney disease","description":"This medicine is used to treat anemia in patients with chronic kidney disease, including those on dialysis and not on dialysis, to reduce the need for blood transfusions.","evidence":"Well-established"},{"condition":"Chemotherapy-induced anemia","description":"It is used to treat anemia in cancer patients receiving myelosuppressive chemotherapy, with the goal of reducing transfusion requirements.","evidence":"Well-established"},{"condition":"Anemia in HIV-infected patients on zidovudine","description":"This medicine is indicated for anemia associated with zidovudine therapy in HIV-infected patients.","evidence":"Well-established"},{"condition":"Anemia in patients undergoing surgery","description":"It may be used to reduce the need for allogeneic blood transfusions in patients undergoing elective surgery with anticipated significant blood loss.","evidence":"Established"}]

Off-label uses: [{"condition":"Anemia in myelodysplastic syndromes","description":"Sometimes used off-label to treat anemia in patients with low-risk myelodysplastic syndromes.","evidence":"Limited"},{"condition":"Anemia of prematurity","description":"Off-label use in premature infants to reduce transfusion needs.","evidence":"Limited"}]

Primary treatment for: Anemia associated with chronic kidney disease

Also treats: Chemotherapy-induced anemia, Anemia in HIV-infected patients on zidovudine, Anemia in patients undergoing surgery

📋 Drug Information

Generic Name(s)Recombinant Human Erythropoietin Alfa (6000IU)
Brand Namevintor 6000iu injection
ManufacturerEmcure Pharmaceuticals Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassBLOOD RELATED
Action ClassErythropoiesis-stimulating agent (ESA)
Route of AdministrationParenteral (intravenous or subcutaneous)
StorageStore refrigerated at 2°C to 8°C. Do not freeze. Do not shake. Protect from light. Keep in original carton until use.
Shelf LifeRefer to the product packaging for the expiration date. Typically 24 months from the date of manufacture when stored properly.
WHO GuidelineWHO guidelines recommend the use of erythropoiesis-stimulating agents for the treatment of anemia in chronic kidney disease and cancer patients, with careful monitoring of hemoglobin levels to avoid excessive increases.
ICMR GuidelineICMR guidelines recommend individualized dosing of erythropoietin in chronic kidney disease patients, with target hemoglobin levels between 10-12 g/dL, and regular monitoring of iron status and blood pressure.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Always administer this medicine under the supervision of a healthcare professional.
2
Monitor hemoglobin levels regularly and adjust dose to maintain target levels (10-12 g/dL for CKD, not exceeding 12 g/dL for cancer).
3
Ensure adequate iron stores before and during therapy; iron deficiency reduces efficacy.
4
Monitor blood pressure closely; hypertension is a common side effect and may require management.
5
Assess for signs of thromboembolism and cardiovascular events, especially in patients with risk factors.
6
Do not use in patients with uncontrolled hypertension or pure red cell aplasia.
7
Educate patients on the importance of reporting sudden loss of efficacy, which may indicate pure red cell aplasia.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

Fatigue and weakness due to anemia
This medicine is commonly prescribed for anemia-related fatigue.
Likely Use
Shortness of breath due to anemia
This medicine can improve oxygen-carrying capacity.
Likely Use
Fever
This medicine is not a primary fever reducer.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionFollowing subcutaneous administration, recombinant human erythropoietin alfa is slowly absorbed, with peak plasma concentrations typically occurring 5-24 hours after injection. The bioavailability is approximately 20-30% for subcutaneous route. Intravenous administration results in immediate peak levels but shorter duration of action.
DistributionThe volume of distribution is approximately 0.05-0.1 L/kg. It is distributed primarily in the plasma and extracellular fluid. It does not cross the blood-brain barrier significantly.
Protein BindingNot established from the available information.
MetabolismThe metabolism of recombinant human erythropoietin alfa is not fully characterized. It is believed to be degraded by general protein catabolism, primarily in the liver and possibly in the kidneys.
Half-LifeThe elimination half-life is approximately 4-13 hours following subcutaneous administration in patients with chronic kidney disease. In healthy individuals, it may be shorter.
ExcretionExcretion pathways are not fully established. It is likely eliminated via protein catabolism and possibly renal excretion.
BioavailabilitySubcutaneous bioavailability is approximately 20-30%.
Onset of ActionThe onset of erythropoietic effect is typically 2-6 weeks after initiation of therapy, as evidenced by a rise in reticulocyte count and hemoglobin.
Peak Plasma TimePeak plasma concentration occurs 5-24 hours after subcutaneous injection.
Duration of ActionThe duration of action is sustained as long as the medicine is administered; hemoglobin levels are maintained with continued dosing.

How It Works

Recombinant human erythropoietin alfa binds to erythropoietin receptors on the surface of erythroid progenitor cells in the bone marrow. This binding activates intracellular signaling pathways, primarily the JAK2/STAT5 pathway, which promotes cell survival, proliferation, and differentiation into mature red blood cells. It also stimulates the release of reticulocytes into the bloodstream, thereby increasing red blood cell production and hemoglobin levels.

Mechanism Steps

1
Binding to erythropoietin receptor: This medicine binds to erythropoietin receptors on the surface of erythroid progenitor cells.
2
Receptor dimerization and activation: Binding induces receptor dimerization and activation of associated JAK2 kinases.
3
JAK2/STAT5 signaling: Activated JAK2 phosphorylates STAT5, which translocates to the nucleus and regulates gene expression.
4
Proliferation and differentiation: This leads to increased proliferation and differentiation of erythroid progenitor cells into mature red blood cells.
5
Increased red blood cell production: The result is an increase in red blood cell mass and hemoglobin levels, improving tissue oxygenation.

💡 How to Take vintor 6000iu injection

Strength: Injection: 6000 IU per vial or prefilled syringe.

1This medicine is administered by a healthcare professional only.
2It is given as an injection under the skin (subcutaneous) or into a vein (intravenous).
3Do not self-administer.
4Follow your doctor's instructions regarding dose and frequency.
5Ensure regular monitoring of blood tests as advised.

Dosage Information

Adult DosageThe dose of this medicine must be individualized by a qualified clinician based on the indication, patient's age, weight, renal and hepatic function, and response to therapy. For chronic kidney disease, typical starting dose is 50-100 IU/kg three times weekly, adjusted to maintain hemoglobin between 10-12 g/dL. For chemotherapy-induced anemia, typical dose is 150 IU/kg three times weekly or 40,000 IU weekly. For zidovudine-treated HIV patients, typical dose is 100 IU/kg three times weekly. Always follow your doctor's prescription.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatrician.
Elderly DosageElderly patients may be more sensitive to the effects of this medicine. Dose selection should be cautious, reflecting the greater frequency of decreased renal, hepatic, or cardiac function. Monitor closely.
Renal ImpairmentIn patients with chronic kidney disease, dose adjustment is required based on hemoglobin levels and clinical response. Monitor renal function and hemoglobin regularly. Dose must be individualized by a qualified clinician.
Hepatic ImpairmentNo specific dose adjustments are established for hepatic impairment. Use with caution and monitor closely.
Maximum Daily DoseNot established from the available information. Dosing is individualized and not typically administered daily.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

⏰ What to Do If You Miss a Dose

📌 Less than half the dosing interval has passed
→ Contact your healthcare provider for guidance.
💡 Do not self-administer; this medicine is given by a professional.
📌 More than half the dosing interval has passed
→ Skip the missed dose and resume the regular schedule.
💡 Do not double dose to catch up.

⚠️ Side Effects of vintor 6000iu injection

✅ Common Side Effects

Hypertension (Common (10-20%))
Monitor blood pressure regularly. If elevated, consult your doctor for management.
Headache (Common (5-10%))
Usually resolves on its own. Consult doctor if persistent or severe.
Fatigue (Common (5-10%))
Ensure adequate rest. Report if worsening.
Diarrhea (Common (5-10%))
Stay hydrated. Consult doctor if severe or persistent.
Nausea (Common (5-10%))
Take with food if possible. Consult doctor if persistent.
Injection site reaction (Common (5-10%))
Apply cold compress. Report if severe or signs of infection.

🚨 Serious Side Effects

Cardiovascular events (myocardial infarction, stroke, thromboembolism) (Uncommon (1-5%))
Seek immediate medical attention if you experience chest pain, shortness of breath, sudden weakness, or swelling in legs.
Seizures (Rare (<1%))
Seek immediate medical attention if seizures occur.
Pure red cell aplasia (Rare (<0.1%))
Report sudden loss of response to therapy, severe anemia, or need for transfusions. Requires immediate medical evaluation.
Anaphylaxis (Rare (<0.1%))
Seek emergency care if you experience rash, itching, swelling of face/lips/throat, difficulty breathing.

⚠️ Rare Side Effects

Hypertensive encephalopathy
Seek immediate medical attention if severe headache, confusion, or visual disturbances occur.
Thrombocytosis
Monitor platelet counts. Consult doctor if elevated.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Other ESAs Major
ACE inhibitors Moderate
ARBs Moderate
Iron supplements Minor

🚨 Major Interactions

  • Other erythropoiesis-stimulating agents

⚡ Moderate Interactions

  • Angiotensin-converting enzyme inhibitors
  • Angiotensin II receptor blockers

🍷 Alcohol Interaction

Alcohol may worsen anemia and increase the risk of hypertension. It is advisable to avoid or limit alcohol consumption while receiving this medicine.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Uncontrolled hypertension","Known hypersensitivity to recombinant human erythropoietin alfa or any excipient","Pure red cell aplasia","Use in patients with chronic kidney disease not on dialysis with hemoglobin >10 g/dL","Use in cancer patients with hemoglobin >12 g/dL"]

⚠️ Warnings & Precautions

["Increased risk of cardiovascular events and thromboembolism when hemoglobin is raised too rapidly or exceeds target levels.","Hypertension may worsen; monitor blood pressure closely.","Seizures have been reported, especially in patients with chronic kidney disease.","Pure red cell aplasia may occur; evaluate if sudden loss of efficacy.","Iron deficiency reduces efficacy; ensure adequate iron stores.","Do not use in patients with uncontrolled hypertension.","Use with caution in patients with history of seizures or cardiovascular disease."]

🤱 Lactation Safety

It is not known whether this medicine is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when administered to a nursing woman. Consult your doctor.

💊 Overdose Management

Overdose may lead to excessive erythropoiesis, resulting in polycythemia and increased risk of thromboembolic events. Treatment is symptomatic and supportive. If overdose is suspected, discontinue the medicine and monitor hemoglobin, hematocrit, and cardiovascular status. Phlebotomy may be considered if severe polycythemia occurs. Seek immediate medical attention.

⏰ Missed Dose

If a dose is missed, contact your healthcare provider for guidance. Do not double the dose to catch up. The dosing schedule is typically individualized; your doctor will advise on the next dose.

Additional Safety Advice

General Safety

This medicine must only be administered by a healthcare professional. Do not self-administer. Regular monitoring of hemoglobin, blood pressure, and iron levels is essential. Target hemoglobin levels should be individualized, generally not exceeding 11-12 g/dL. Iron supplementation is often required to ensure adequate response. Report any signs of blood clots, such as chest pain, shortness of breath, or swelling in legs, immediately. Avoid use in patients with uncontrolled hypertension. Do not use if you have known hypersensitivity to the active ingredient. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding. Store this medicine refrigerated at 2-8°C; do not freeze. Keep out of reach of children.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients may be more sensitive to the effects of this medicine. Dose selection should be cautious, and blood pressure and hemoglobin should be monitored closely.

🤰 Pregnancy Planning (TTC)

If you are planning pregnancy, consult your doctor. This medicine is not recommended during pregnancy unless clearly needed. Discuss risks and benefits.

🏥 Post-Surgery Considerations

This medicine may be used to reduce the need for blood transfusions after surgery. Monitor hemoglobin and blood pressure closely. Follow your surgeon's instructions.

🦷 Dental Procedures

Inform your dentist that you are receiving this medicine. No specific precautions are established, but maintain good oral hygiene and report any bleeding issues.

💚 Lifestyle Tips for Better Results

🏃
Maintain a healthy diet rich in iron, vitamin B12, and folate.
🥗
Stay hydrated unless advised otherwise.
😴
Monitor your blood pressure regularly at home.
💧
Engage in light physical activity as tolerated.
🧘
Avoid smoking and limit alcohol consumption.
🌞
Keep all follow-up appointments for blood tests.

🏋️ Exercise Considerations

Patients with anemia may experience fatigue and shortness of breath. Engage in light to moderate exercise as tolerated. Avoid strenuous activity until hemoglobin levels improve. Consult your doctor before starting any exercise program.

🥗 Diet Recommendations

Include iron-rich foods like lean meat, beans, and leafy greens.
Ensure adequate vitamin C to enhance iron absorption.
Avoid excessive tea or coffee with meals as they inhibit iron absorption.
Consider iron supplements if prescribed.

💼 Impact on Daily Work & Life

This medicine may cause dizziness or seizures in some patients. Avoid driving or operating heavy machinery until you know how it affects you. Most patients can continue their daily activities, but fatigue may limit strenuous work until anemia improves.

🛑 When to Stop This Medicine

Do not stop this medicine without consulting your doctor. Stopping abruptly may lead to worsening anemia. Your doctor will determine when to stop based on your hemoglobin levels and clinical response.

📅 Long-Term Use Effects

Long-term use of this medicine may increase the risk of cardiovascular events, thromboembolism, and hypertension. Regular monitoring of hemoglobin, blood pressure, and iron levels is essential. Pure red cell aplasia is a rare but serious complication that may occur after long-term use. The dose should be adjusted to maintain target hemoglobin levels and minimize risks.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Iron supplementation

May be used alone or in combination with this medicine to treat iron deficiency anemia.

Evidence: Well-established
Blood transfusion

Used for severe anemia or when ESAs are ineffective.

Evidence: Well-established

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

No specific interactions with vaccines are established. However, consult your doctor before receiving any vaccine while on this medicine.

📦 Storage Guide

✅ DO

Store refrigerated at 2-8°C

❌ DON'T

Do not freeze

✅ DO

Keep in original carton to protect from light

❌ DON'T

Do not shake

✅ DO

Keep out of reach of children

❌ DON'T

Do not use if expired

✈️ Traveling with This Medicine

When traveling with this medicine, carry it in its original packaging with the prescription label. Keep it refrigerated using a cool pack or insulated bag. Carry a copy of your prescription and a doctor&#039;s letter explaining the medical need. Check airline and customs regulations for carrying injectable medications. Do not freeze. If traveling across time zones, consult your doctor for dose timing adjustments.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 58-year-old man with chronic kidney disease on dialysis
He had been suffering from severe fatigue and shortness of breath due to anemia. His doctor started him on this medicine three times a week. After 6 weeks, his hemoglobin improved from 8 g/dL to 10.5 g/dL, and he felt more energetic. He learned to monitor his blood pressure and report any unusual symptoms.
💡 Lesson: Regular dosing and monitoring are key to improving anemia symptoms and quality of life.
👤 A 45-year-old woman undergoing chemotherapy for breast cancer
She developed anemia during chemotherapy, causing extreme tiredness. Her oncologist prescribed this medicine weekly. With treatment, her hemoglobin stabilized, and she required fewer blood transfusions. She was advised to take iron supplements and monitor for any signs of blood clots.
💡 Lesson: This medicine can effectively manage chemotherapy-induced anemia, but close monitoring for side effects is essential.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: It typically takes 2-6 weeks to see an increase in hemoglobin levels. Regular monitoring is required.

Q: Can I self-administer this injection?

A: No, this medicine must be administered by a healthcare professional.

Q: What should I do if I miss a dose?

A: Contact your healthcare provider for guidance. Do not double the dose.

Q: Is it safe during pregnancy?

A: Consult your doctor. It is not recommended unless clearly needed.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine long-term?
  • Will it affect my kidney function?
  • Can I drive after taking this medicine?
  • Does it interact with my blood pressure medicine?
  • What if I miss a dose?
  • Can I drink alcohol while taking this?

🔄 Substitutes for vintor 6000iu injection

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: This medicine can be used as a performance enhancer by athletes.
    Fact: This medicine is a prescription medication for specific medical conditions and should not be used for performance enhancement. It can cause serious cardiovascular risks.
  • Myth: This medicine can be taken orally.
    Fact: This medicine is a protein and would be digested if taken orally. It must be given by injection.
  • Myth: More is better; higher doses increase energy.
    Fact: Higher doses can dangerously increase hemoglobin and risk of blood clots, heart attack, and stroke. Dose is carefully individualized.

🔄 Alternative Options

Generic Alternatives

  • Recombinant human erythropoietin alfa

Brand Alternatives

  • Epofit 6000 IU Injection
  • Eprex 6000 IU Injection
  • Recormon 6000 IU Injection

📊 Comparison with Similar Medicines

[{"medicine":"Epofit 6000 IU","active_ingredient":"Recombinant human erythropoietin alfa","route":"Parenteral","frequency":"Three times weekly or weekly","notes":"Short-acting ESA"},{"medicine":"Darbepoetin alfa","active_ingredient":"Darbepoetin alfa","route":"Parenteral","frequency":"Weekly or every 2 weeks","notes":"Longer-acting ESA"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory